Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Mesenchymal stem cell"" wg kryterium: Temat


Tytuł:
Safety and Efficacy of the Intra-articular Injection of Mesenchymal Stem Cells for the Treatment of Osteoarthritic Knee: A 5-Year Follow-up Study.
Autorzy:
Kim KI; Department of Orthopaedic Surgery, Center for Joint Diseases, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.; Department of Orthopaedic Surgery, School of Medicine, Kyung Hee University, Seoul, South Korea.
Lee WS; Department of Orthopaedic Surgery, College of Medicine, Gangnam Severance Hospital, Yonsei University, Seoul, South Korea.
Kim JH; Department of Orthopaedic Surgery, Center for Joint Diseases, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Bae JK; Department of Orthopaedic Surgery, Center for Joint Diseases, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Jin W; Department of Radiology, Kyung Hee University Hospital at Gandong, Seoul, South Korea.
Pokaż więcej
Źródło:
Stem cells translational medicine [Stem Cells Transl Med] 2022 Jun 22; Vol. 11 (6), pp. 586-596.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Mesenchymal Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*
Osteoarthritis, Knee*/diagnostic imaging
Osteoarthritis, Knee*/pathology
Osteoarthritis, Knee*/therapy
Follow-Up Studies ; Humans ; Injections, Intra-Articular ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment.
Autorzy:
Raza SS; Department of Stem Cell Biology and Regenerative Medicine, Era's Lucknow Medical College Hospital, Era University, Lucknow, Uttar Pradesh, India. Electronic address: .
Khan MA; Era University, Lucknow, Uttar Pradesh, India.
Pokaż więcej
Źródło:
Cytotherapy [Cytotherapy] 2022 Aug; Vol. 24 (8), pp. 755-766. Date of Electronic Publication: 2020 Jul 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/therapy
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*
Respiratory Distress Syndrome*
Humans ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
A study of diabetes-induced erectile dysfunction treated with human umbilical cord mesenchymal stem cells.
Autorzy:
Wang S; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Zhang A; Department of Neonatology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.; Department of Neonatology, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China.
Liu K; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Pan Y; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Kang J; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Niu S; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Song Y; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Zhang Z; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Li Y; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Liu L; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Liu X; Department of Urology, Tianjin Medical University General Hospital, Tianjin, China.
Pokaż więcej
Źródło:
Andrologia [Andrologia] 2022 Aug; Vol. 54 (7), pp. e14440. Date of Electronic Publication: 2022 Apr 12.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Experimental*/complications
Diabetes Mellitus, Experimental*/metabolism
Diabetes Mellitus, Experimental*/therapy
Erectile Dysfunction*/etiology
Erectile Dysfunction*/metabolism
Erectile Dysfunction*/therapy
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*/metabolism
Animals ; Humans ; Male ; Rats ; Rats, Sprague-Dawley ; Toll-Like Receptor 4 ; Umbilical Cord/metabolism ; Vascular Endothelial Growth Factor A
Czasopismo naukowe
Tytuł:
The effect of mesenchymal stem cell lyophilizate on the recovery of the zone of stasis following thermal burns.
Autorzy:
Tutak FN; Adıyaman University, Faculty of Medicine, Department of Plastic, Reconstructive and Aesthetic Surgery, Turkey. Electronic address: .
Doğan F; Adıyaman University, Faculty of Medicine, Department of Plastic, Reconstructive and Aesthetic Surgery, Turkey. Electronic address: .
Annaç E; Adıyaman University, Faculty of Medicine, Department of Plastic, Reconstructive and Aesthetic Surgery, Turkey. Electronic address: .
Pokaż więcej
Źródło:
Burns : journal of the International Society for Burn Injuries [Burns] 2022 Aug; Vol. 48 (5), pp. 1221-1229. Date of Electronic Publication: 2021 Oct 30.
Typ publikacji:
Journal Article
MeSH Terms:
Burns*/pathology
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Animals ; Disease Models, Animal ; Rats ; Wound Healing
Czasopismo naukowe
Tytuł:
Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Autorzy:
Aghayan HR; Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Salimian F; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, P.O. BOX: 15179/64311, Tehran, Iran.
Abedini A; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fattah Ghazi S; Department of Anesthesiology and Critical Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Yunesian M; Department of Environmental Health Engineering, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Alavi-Moghadam S; Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Makarem J; Department of Anesthesiology and Critical Care, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Majidzadeh-A K; Genetics Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.
Hatamkhani A; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, P.O. BOX: 15179/64311, Tehran, Iran.
Moghri M; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, P.O. BOX: 15179/64311, Tehran, Iran.
Danesh A; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Haddad-Marandi MR; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, P.O. BOX: 15179/64311, Tehran, Iran.
Sanati H; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, P.O. BOX: 15179/64311, Tehran, Iran.
Abbasvandi F; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, P.O. BOX: 15179/64311, Tehran, Iran.
Arjmand B; Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Azimi P; Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ghavamzadeh A; Cancer and Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran. .
Sarrami-Forooshani R; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, P.O. BOX: 15179/64311, Tehran, Iran. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Jul 28; Vol. 13 (1), pp. 365. Date of Electronic Publication: 2022 Jul 28.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
COVID-19*/therapy
Hematopoietic Stem Cell Transplantation*
Mesenchymal Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*
Respiratory Distress Syndrome*/therapy
Humans ; Iran ; Pandemics ; SARS-CoV-2
Czasopismo naukowe
Tytuł:
Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?
Autorzy:
Blando S; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Anchesi I; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Mazzon E; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Gugliandolo A; IRCCS Centro Neurolesi 'Bonino-Pulejo', Via Provinciale Palermo, Contrada Casazza, 98124 Messina, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 07; Vol. 23 (14). Date of Electronic Publication: 2022 Jul 07.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*/metabolism
Spinal Cord Injuries*/metabolism
Animals ; Humans ; Rats ; Rats, Sprague-Dawley ; Spinal Cord/metabolism ; Tissue Scaffolds
Czasopismo naukowe
Tytuł:
Chorion-derived perinatal mesenchymal stem cells improve cardiac function and vascular regeneration: Preferential treatment for ischemic heart disease.
Autorzy:
Park YS; Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Park BW; Department of Medical Life Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Choi H; Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Lee SH; Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Kim M; Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea.
Park HJ; Department of Medical Life Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul 06591, Korea.
Kim IB; Department of Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Catholic Neuroscience Institute, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea; Catholic Institute for Applied Anatomy, College of Medicine, The Catholic University of Korea, Seoul 06591, Korea. Electronic address: .
Pokaż więcej
Źródło:
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese [Hellenic J Cardiol] 2022 Jul-Aug; Vol. 66, pp. 52-58. Date of Electronic Publication: 2022 May 29.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*/metabolism
Myocardial Infarction*
Animals ; Chorion/metabolism ; Disease Models, Animal ; Rats ; Stroke Volume ; Troponin T/metabolism ; Ventricular Function, Left
Czasopismo naukowe
Tytuł:
Evaluation of antioxidant and antibacterial effects of lactobacilli metabolites- preconditioned bone marrow mesenchymal stem cells in skin lesions amelioration.
Autorzy:
Kazemi A; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: .
Ataellahi Eshkoor P; Islamic Azad university of sciences and researches, Tehran, Iran. Electronic address: .
Saeedi P; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: .
Halabian R; Applied Microbiology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran. Electronic address: .
Pokaż więcej
Źródło:
Bioorganic chemistry [Bioorg Chem] 2022 Jul; Vol. 124, pp. 105797. Date of Electronic Publication: 2022 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Animals ; Anti-Bacterial Agents/metabolism ; Anti-Bacterial Agents/pharmacology ; Antioxidants/metabolism ; Antioxidants/pharmacology ; Hydrogen Peroxide/metabolism ; Hydrogen Peroxide/pharmacology ; Lactobacillus ; Mice
Czasopismo naukowe
Tytuł:
Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial.
Autorzy:
Izadi M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Sadr Hashemi Nejad A; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Moazenchi M; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Masoumi S; Department of Epidemiology and Biostatistics, Tehran University of Medical Sciences, Tehran, Iran.
Rabbani A; Growth and Development Research Center, Children's Medical Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Kompani F; Division of Hematology and Oncology, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Hedayati Asl AA; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Hematology-Oncology and Stem Cell Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Abbasi Kakroodi F; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Jaroughi N; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Mohseni Meybodi MA; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Setoodeh A; Division of Pediatrics Endocrinology, Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Abbasi F; Growth and Development Research Center, Children's Medical Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran.
Hosseini SE; Department of Medical-Surgical Nursing, School of Nursing and Midwifery, Iran University of Medical Sciences, Tehran, Iran.
Moeini Nia F; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Salman Yazdi R; Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Navabi R; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Hajizadeh-Saffar E; Advanced Therapy Medicinal Product Technology Development Center (ATMP-TDC), Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. .; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. .; Department of Diabetes, Obesity, and Metabolism, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. .
Baharvand H; Department of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. .; Department of Developmental Biology, School of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, Tehran, Iran. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Jun 20; Vol. 13 (1), pp. 264. Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Diabetes Mellitus, Type 1*/therapy
Mesenchymal Stem Cell Transplantation*/adverse effects
Mesenchymal Stem Cell Transplantation*/methods
Child ; Cytokines ; Glycated Hemoglobin A ; Humans ; Hypoglycemic Agents ; Iran ; Quality of Life
Czasopismo naukowe
Tytuł:
Intrauterine Growth Restriction (IUGR) as a potential target for transamniotic stem cell therapy.
Autorzy:
Labuz DF; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA, United States of America.
Whitlock AE; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA, United States of America.
Kycia I; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA, United States of America.
Zurakowski D; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA, United States of America.
Fauza DO; Department of Surgery, Boston Children's Hospital/Harvard Medical School, Boston, MA, United States of America. Electronic address: .
Pokaż więcej
Źródło:
Journal of pediatric surgery [J Pediatr Surg] 2022 Jun; Vol. 57 (6), pp. 999-1003. Date of Electronic Publication: 2022 Feb 14.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Amniotic Fluid ; Animals ; Female ; Fetal Growth Retardation/therapy ; Humans ; Hypoxia ; Placenta ; Pregnancy ; Rats
Czasopismo naukowe
Tytuł:
Intra-amniotic transplantation of brain-derived neurotrophic factor-modified mesenchymal stem cells treatment for rat fetuses with spina bifida aperta.
Autorzy:
Ma W; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
Wei X; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
Gu H; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
Liu D; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
Luo W; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
Cao S; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
Jia S; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
He Y; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China.
Chen L; Department of Ultrasound, Shengjing Hospital, China Medical University, Shenyang, China.
Bai Y; Department of Pediatric Surgery, Shengjing Hospital, China Medical University, Shenyang, China.
Yuan Z; Key Laboratory of Health Ministry for Congenital Malformation, Department of Pediatric Surgery, Shengjing Hospital, China Medical University, No. 36, Sanhao Street, Heping District, Shenyang, 110004, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Aug 13; Vol. 13 (1), pp. 413. Date of Electronic Publication: 2022 Aug 13.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*
Spina Bifida Cystica*/chemically induced
Spina Bifida Cystica*/therapy
Amniotic Fluid ; Animals ; Brain-Derived Neurotrophic Factor/genetics ; Female ; Pregnancy ; Rats
Czasopismo naukowe
Tytuł:
Infusion of two-dose mesenchymal stem cells is more effective than a single dose in a dilated cardiomyopathy rat model by upregulating indoleamine 2,3-dioxygenase expression.
Autorzy:
Gong C; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
Chang L; Department of Cardiology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China.
Sun X; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
Qi Y; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
Huang R; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
Chen K; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
Wang B; Clinical Stem Cell Centor, Nanjing Drum Tower Hospital, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
Kang L; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
Wang L; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China. .; Department of Cardiology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China. .
Xu B; Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China. .; Department of Cardiology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing, 210008, Jiangsu, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Aug 12; Vol. 13 (1), pp. 409. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Cardiomyopathy, Dilated*/genetics
Cardiomyopathy, Dilated*/metabolism
Cardiomyopathy, Dilated*/therapy
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*/metabolism
Animals ; Fibrosis ; Humans ; Indoleamine-Pyrrole 2,3,-Dioxygenase/genetics ; Indoleamine-Pyrrole 2,3,-Dioxygenase/metabolism ; Inflammation/metabolism ; Male ; Rats ; Rats, Sprague-Dawley
Czasopismo naukowe
Tytuł:
Mesenchymal stem cells and their derived small extracellular vesicles for COVID-19 treatment.
Autorzy:
Huang Y; Departments of Geriatrics, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China.
Li X; Departments of Infectious Disease, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China. .
Yang L; Departments of Geriatrics, The First Affiliated Hospital of China Medical University, Shenyang, 110001, Liaoning, People's Republic of China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Aug 12; Vol. 13 (1), pp. 410. Date of Electronic Publication: 2022 Aug 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
COVID-19*/drug therapy
COVID-19*/therapy
Coronavirus Infections*/therapy
Extracellular Vesicles*
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Humans
SCR Protocol:
COVID-19 drug treatment
Czasopismo naukowe
Tytuł:
Biological mechanisms and applied prospects of mesenchymal stem cells in premature ovarian failure.
Autorzy:
Shi L; The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.
Zhang Z; The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.; Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang Province, People's Republic of China.
Deng M; Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang Province, People's Republic of China.
Zheng F; Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang Province, People's Republic of China.
Liu W; Department of Obstetrics and Gynecology, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang Province, People's Republic of China.
Ye S; The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People's Republic of China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2022 Aug 12; Vol. 101 (32), pp. e30013.
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Primary Ovarian Insufficiency*/therapy
Animals ; Cytokines ; Disease Models, Animal ; Female ; Humans
Czasopismo naukowe
Tytuł:
Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
Autorzy:
Zhang W; Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Ling Q; Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Wang B; Clinical Stem Cell Center, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Wang K; Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Pang J; Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Lu J; Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China. .
Bi Y; Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China. .
Zhu D; Department of Endocrinology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321, Zhongshan Road, Nanjing, 210008, Jiangsu, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Aug 08; Vol. 13 (1), pp. 406. Date of Electronic Publication: 2022 Aug 08.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Experimental*/therapy
Diabetes Mellitus, Type 1*/therapy
Insulins*
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*
Animals ; Blood Glucose ; Bone Marrow ; Bone Marrow Cells ; Mice ; Mice, Inbred NOD ; Retrospective Studies ; Umbilical Cord
Czasopismo naukowe
Tytuł:
Cobalt Ferrite Magnetic Nanoparticles for Tracing Mesenchymal Stem Cells in Tissue: A Preliminary Study.
Autorzy:
Večerić-Haler Ž; Department of Nephrology, University Medical Center Ljubljana, 1000 Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Kojc N; Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Wechtersbach K; Institute of Pathology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Perše M; Medical Experimental Centre, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Erman A; Institute of Cell Biology, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Aug 05; Vol. 23 (15). Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Acute Kidney Injury*
Magnetite Nanoparticles*/chemistry
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*
Nanoparticles*/chemistry
Animals ; Cisplatin ; Cobalt/chemistry ; Ferric Compounds ; Mice
Czasopismo naukowe
Tytuł:
Endogenous Follistatin-like 1 guarantees the immunomodulatory properties of mesenchymal stem cells during liver fibrotic therapy.
Autorzy:
Zheng X; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.; Department of Immunology, Fourth Military Medical University, Xi'an, 710032, China.
Zhou X; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Ma G; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Yu J; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Zhang M; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Yang C; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Hu Y; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Ma S; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Han Z; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China.
Ning W; State Key Laboratory of Medicinal Chemical Biology, College of Life Sciences, Nankai University, Tianjin, 300071, China.
Jin B; Department of Immunology, Fourth Military Medical University, Xi'an, 710032, China.
Zhou X; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China. .
Wang J; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China. .
Han Y; State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, 127 Changle West Road, Xi'an, 710032, China. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2022 Aug 05; Vol. 13 (1), pp. 403. Date of Electronic Publication: 2022 Aug 05.
Typ publikacji:
Journal Article
MeSH Terms:
Follistatin-Related Proteins*/genetics
Mesenchymal Stem Cell Transplantation*
Mesenchymal Stem Cells*/metabolism
Animals ; Follistatin/adverse effects ; Follistatin/metabolism ; Humans ; Liver Cirrhosis/chemically induced ; Liver Cirrhosis/genetics ; Liver Cirrhosis/therapy ; Mice
Czasopismo naukowe
Tytuł:
Longitudinal electrophysiological changes after mesenchymal stem cell transplantation in a spinal cord injury rat model.
Autorzy:
Maeda Y; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Takeda M; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Mitsuhara T; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Okazaki T; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Shimizu K; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Kuwabara M; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Hosogai M; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Yuge L; Division of Bio-Environmental Adaptation Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Horie N; Department of Neurosurgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Aug 05; Vol. 17 (8), pp. e0272526. Date of Electronic Publication: 2022 Aug 05 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*/metabolism
Spinal Cord Injuries*
Animals ; Humans ; Paralysis/metabolism ; Rats ; Recovery of Function/physiology ; Spinal Cord
Czasopismo naukowe
Tytuł:
Transplantation of mesenchymal stem cells for prevention of acute myocardial infarction induced heart failure: study protocol of a phase III randomized clinical trial (Prevent-TAHA8).
Autorzy:
Attar A; Department of Cardiovascular Medicine, TAHA Clinical Trial Group, Shiraz University of Medical Sciences, Zand Street, Shiraz, 71344-1864, Iran. .
Monabati A; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.; Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.
Montaseri M; Department of Cardiovascular Medicine, TAHA Clinical Trial Group, Shiraz University of Medical Sciences, Zand Street, Shiraz, 71344-1864, Iran.; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Vosough M; Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
Hosseini SA; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Kojouri J; Department of Cardiovascular Medicine, TAHA Clinical Trial Group, Shiraz University of Medical Sciences, Zand Street, Shiraz, 71344-1864, Iran.
Abdi-Ardekani A; Department of Cardiovascular Medicine, TAHA Clinical Trial Group, Shiraz University of Medical Sciences, Zand Street, Shiraz, 71344-1864, Iran.
Izadpanah P; Department of Cardiovascular Medicine, TAHA Clinical Trial Group, Shiraz University of Medical Sciences, Zand Street, Shiraz, 71344-1864, Iran.
Azarpira N; Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Pouladfar G; Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran.
Ramzi M; Department of Pathology, Shiraz University of Medical Sciences, Shiraz, Iran.
Pokaż więcej
Źródło:
Trials [Trials] 2022 Aug 04; Vol. 23 (1), pp. 632. Date of Electronic Publication: 2022 Aug 04.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Heart Failure*/etiology
Heart Failure*/prevention & control
Mesenchymal Stem Cell Transplantation*
Myocardial Infarction*/complications
Clinical Trials, Phase III as Topic ; Humans ; Multicenter Studies as Topic ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
The effect of poly I:C or LPS priming on the therapeutic efficacy of mesenchymal stem cells in an adjuvant-induced arthritis rat model.
Autorzy:
Zolfaghari S; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, 1591639675, Iran.; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Milan PB; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, 1591639675, Iran.; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Dehpour AR; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Fomeshi MR; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, 1591639675, Iran.; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Eskandari F; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, 1591639675, Iran.; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Ebrahimi L; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, 1591639675, Iran.; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.
Hashemi SM; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, 1985717434, Iran. .
Joghataei MT; Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, 1591639675, Iran. .; Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran. .
Pokaż więcej
Źródło:
Pharmacological reports : PR [Pharmacol Rep] 2022 Aug; Vol. 74 (4), pp. 654-668. Date of Electronic Publication: 2022 Jul 17.
Typ publikacji:
Journal Article
MeSH Terms:
Arthritis, Experimental*/chemically induced
Arthritis, Experimental*/therapy
Mesenchymal Stem Cell Transplantation*/methods
Mesenchymal Stem Cells*
Animals ; Cytokines ; Ligands ; Lipopolysaccharides/pharmacology ; Male ; Poly I-C/pharmacology ; Rats ; Rats, Wistar
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz